High-dose recombinant interleukin-2/verapamil combination in advanced cancer

被引：4
|
作者：
Tagliaferri, P [1 ]
Correale, P [1 ]
Mottola, M [1 ]
deSimone, G [1 ]
Montesarchio, V [1 ]
Matano, E [1 ]
Rea, A [1 ]
Morabito, A [1 ]
Famiani, M [1 ]
Ciardiello, F [1 ]
Tortora, G [1 ]
Caraglia, M [1 ]
Barile, C [1 ]
Palmieri, G [1 ]
Bianco, AR [1 ]
机构：
[1] UNIV NAPLES FEDERICO II,IST MED INTERNA & MALATTIE DISMETAB,I-80131 NAPLES,ITALY
来源：
EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 08期
关键词：
D O I：
10.1016/0959-8049(96)00126-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1436 / 1437
页数：2
相关论文
共 50 条
  • [1] High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
    Silk, Ann W.
    Kaufman, Howard L.
    Curti, Brendan
    Mehnert, Janice M.
    Margolin, Kim
    McDermott, David
    Clark, Joseph
    Newman, Jenna
    Bommareddy, Praveen K.
    Denzin, Lisa
    Najmi, Saltanat
    Haider, Azra
    Shih, Weichung
    Kane, Michael P.
    Zloza, Andrew
    [J]. FRONTIERS IN ONCOLOGY, 2020, 9
  • [2] The treatment of disseminated skin melanoma with high-dose recombinant interleukin-2 in combination with chemotherapy
    Streltsova, O.
    Baranau, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN ADVANCED CUTANEOUS T-CELL LYMPHOMA
    MAROLLEAU, JP
    BACCARD, M
    FLAGEUL, B
    RYBOJAD, M
    LAROCHE, L
    VEROLA, O
    BRANDELY, M
    MOREL, P
    GISSELBRECHT, C
    [J]. ARCHIVES OF DERMATOLOGY, 1995, 131 (05) : 574 - 579
  • [4] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 AND ACUTE MYELOID LEUKEMIAS IN RELAPSE
    MARANINCHI, D
    BLAISE, D
    VIENS, P
    BRANDELY, M
    OLIVE, D
    LOPEZ, M
    SAINTY, D
    MARIT, G
    STOPPA, AM
    REIFFERS, J
    GRATECOS, N
    BERTAUPEREZ, P
    MANNONI, P
    MAWAS, C
    HERCEND, T
    SEBAHOUN, G
    CARCASSONNE, Y
    [J]. BLOOD, 1991, 78 (09) : 2182 - 2187
  • [5] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 FOR CHRONIC VIRAL-HEPATITIS
    BACH, N
    SCHAFFNER, F
    LIN, SC
    [J]. LANCET, 1989, 2 (8657): : 281 - 281
  • [6] The experience of administration of high-dose recombinant interleukin-2 in combination with chemotherapy in the management of disseminated skin melanoma
    Streltsova, Olga
    Baranau, Yauheni Valerievich
    Javrid, Edvard
    Barmotska, Maxim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] THE TREATMENT OF PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
    ROSENBERG, SA
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY, 1987, 23 (03): : A52 - A52
  • [8] THE EFFECT OF RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH MITOMYCIN-C ON ADVANCED CANCER
    AKIYOSHI, T
    ARINAGA, S
    NANBARA, S
    KARIMINE, N
    INOUE, H
    TAKAMUKU, K
    ABE, R
    WATANABE, D
    NAGAMATSU, M
    MATSUOKA, H
    UEO, H
    [J]. JAPANESE JOURNAL OF SURGERY, 1990, 20 (03): : 365 - 368
  • [9] COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2
    THIJS, LG
    HACK, CE
    VANSCHIJNDEL, RJMS
    NUIJENS, JH
    WOLBINK, GJ
    EERENBERGBELMER, AJM
    VANDERVALL, H
    WAGSTAFF, J
    [J]. LANCET, 1989, 2 (8659): : 395 - 395
  • [10] Managing toxicities of high-dose interleukin-2
    Schwartz, RN
    Stover, L
    Dutcher, J
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (11): : 11 - 20
12345